Navigation Links
Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
Date:12/9/2008

, Bradford, United Kingdom.

Using data from the Phase III TRIUMPH study of Soliris, Dr. Hill and her colleagues evaluated the efficacy of Soliris in the regulation of cell-free plasma hemoglobin levels, nitric oxide depletion and subsequent cardiovascular morbidities in patients with PNH. This analysis found that 47 percent of patients with PNH (34 of 73) suffered from pulmonary hypertension before starting the trial. In this study, PAH was measured by an elevated blood level of NT-proBNP, which has been shown to be highly predictive of PAH and an independent predictor of mortality in other hemolytic diseases. (2) At the start of the study, levels of hemolysis and nitric oxide consumption were shown to be much greater in PNH (more than 6- and 10-fold, respectively) than in patients with other hemolytic diseases.

Patients treated with Soliris experienced a 50 percent reduction in the incidence of PAH over the course of the 26-week treatment period, from 52.5 percent to 26.3 percent, while PAH did not change with placebo (39.4% to 43.8%) (P<0.001). Additionally, Soliris-treated PNH patients experienced significantly improved shortness of breath compared to placebo, as measured by the EORTC QLQ-C30 quality of life survey (P<0.001).

"A careful analysis of blood levels in PNH patients shows that hemolysis, the red blood cell destruction that defines the disease, consumes nitric oxide in the blood which is likely to result in an increase in cardiovascular complications as shown in other hemolytic diseases," said Dr. Hill. "This study confirms that PAH is common in hemolytic PNH patients and also suggests that the anti-hemolytic effect of Soliris treatment significantly increases nitric oxide and consequently reduces pulmonary hypertension in patients with PNH."

Pulmonary artery hypertension is a rare, progressive disorder characterized by high blood pressure (hypertension) of the pulmon
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
2. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
3. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
6. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
7. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
8. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
9. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
10. NIST studies how new helium ion microscope measures up
11. SpectraCell Laboratories Now Measures Vitamin C

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009).../--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalspec...thassubmittedaMAAtotheEuropeanMedicinesAgencyfor,v...apyindevelopment,forthetreatmentofType1Gaucherdise...erasealfathathasbeensubmitted,withprevious,submiss...balsupplyshortageofthecurrentlyapprovedandmarketed...
(Date:11/24/2009)...tomers with Partners Validated to Process and Anal... Ottawa, ON (PRWEB) Novemb...f products for biological sample collection, stabi...global partner program. The program offers signifi...ity and is designed to help partners scale and dif...
(Date:11/23/2009)...ami very high-tech origami. , Researchers at the... for fabricating three-dimensional, single-crystal...g photolithography and a self-folding process driv... few microns thick, offer mechanical bendability t...e material. , "This is a completely different app...
(Date:11/23/2009)...Call/-YMBioSciencesInc.(NYSEAmex: YMI ;TSX:YM),ali...ndadvancesadiverseportfolioofpromisingcancer-relat...edthatCytopia(ASX:CYT)hascommencedenrollmentofaPha...teredJAK1/JAK2inhibitor.Thetrialisbeingconductedat...topiaintoYMhasbeenpreviouslyannouncedandispendinga...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...d publications used to uphold a challenge to its s...nd proliferation of human embryonic stem cells, th... a response refuting an initial determination by...observations on relevancy, made by Carl Gulbrandse...r. Colin Stewart , a stem cell researcher at the I...
...in improperly apply its five percent sales tax to ... ,The Wisconsin Supreme Court will decide that q... and there is an estimated $350 million at stake f...,000 for Menasha Corp. , ,At issue is the definiti...f software is not subject to the state sales tax. ...
...r who built and rebuilt technology-based companies... Day award, which will be presented June 13 at the...e. , ,Eddy, who has overcome business and personal...e award and speak during a conference luncheon at ... involved in the technology industry for more than...
Other Biology Technology:WARF questions relevancy of documents used to uphold patent challenge 2WARF questions relevancy of documents used to uphold patent challenge 3
(Date:11/23/2009)...ed strain of the deadly superbug MRSAan infection-...icsposes a far greater health threat than previous...ording to a study in the December issue of Emergi...sily picked up in fitness centers, schools, and ot...rden of MRSA within hospitals, the report found. ,...
(Date:11/23/2009)...of day matters to forest trees dealing with drough... team led by Professor Malcolm Campbell, Universit...arch and colleagues in the department of cell and ...pitalizing on their previous work to decode the ge...d how poplar trees use their 45,000 genes to respo...
(Date:11/23/2009)...ants gathered this week for the seventh annual Nat.... This year,s topic, "Synthetic Biology," brought ...chers to explore the engineering, scientific, and ...nthetic biology. , Bonnie L. Bassler, professor ...his year,s conference chair, challenged the attend...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Study Shows 1 25 of Americans Have Been Infected With West Nile 56658 1Study Shows 1 25 of Americans Have Been Infected With West Nile 56658 2Study Shows 1 25 of Americans Have Been Infected With West Nile 56658 3IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting Safety Concerns and Global Complexity 56655 1IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting Safety Concerns and Global Complexity 56655 2IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting Safety Concerns and Global Complexity 56655 3IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting Safety Concerns and Global Complexity 56655 4Kool Smiles Joins Governor OMalley to Announce New Healthy Smiles Tour 56652 1Kool Smiles Joins Governor OMalley to Announce New Healthy Smiles Tour 56652 2Kool Smiles Joins Governor OMalley to Announce New Healthy Smiles Tour 56652 3
...National Institute of Child Health and Development...awarded Albert Einstein College of Medicine of Yes...a Specialized Cooperative Center Program in Reprod...ly 13 such centers in the country and the only one... wide range of diseases of the female reproductive...
...ty] People have always been fascinated by bats, b... to how bats fly and their bizarre habit of sleepi...bats arrive at their daytime perches. , A Brown U...nt the landing approaches of three species of bats...ees. What they found was surprising: Not all bats ...
...mshoe. The University of Alberta medical geneticis...glaucoma. , Glaucoma is a leading cause of blindne...ng the brain from understanding what patients see....36 and glaucoma, but have been unable to figure ou...ations of the gene get glaucoma while others don,t...
Other Biology News:NIH funds research center for women's reproductive health at Einstein 2NIH funds research center for women's reproductive health at Einstein 3Brown-led team offers first look at how bats land 2Brown-led team offers first look at how bats land 3Genetic sleuth solves glaucoma mystery 2
...tinal (CIAP), catalyzes the hydrolysis of 5-phosph...ucleoside triphosphates. This enzyme is used to pr...ed cloning vector DNA by removing phosphate groups...dephosphorylation of 5 phosphorylated ends of DNA ...
ELISA Plate Sealers, 100 Pack from R&D Systems
Rat Anti-Mouse P-Selectin / CD62P Monoclonal Antibody, Unconjugated, Clone 127933 from R&D Systems
Mouse Anti-Mouse IgD Chain C Monoclonal Antibody, Unconjugated, Clone AMS 9.1 from Santa Cruz Biotechnology, Inc.
Biology Products: